SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-019644
Filing Date
2018-08-07
Accepted
2018-08-07 07:32:24
Documents
59
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q sage-10q_20180630.htm 10-Q 2002335
2 EX-31.1 sage-ex31_10.htm EX-31 9355
3 EX-31.2 sage-ex31_6.htm EX-31 9289
4 EX-32.1 sage-ex32_9.htm EX-32 7620
5 GRAPHIC grgl0mnrqeka000001.jpg GRAPHIC 31773
  Complete submission text file 0001564590-18-019644.txt   6900086

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT sage-20180630.xml EX-101.INS 1587890
7 XBRL TAXONOMY EXTENSION SCHEMA sage-20180630.xsd EX-101.SCH 45247
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sage-20180630_cal.xml EX-101.CAL 39920
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sage-20180630_def.xml EX-101.DEF 164787
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE sage-20180630_lab.xml EX-101.LAB 327048
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sage-20180630_pre.xml EX-101.PRE 275164
Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Filer) CIK: 0001597553 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36544 | Film No.: 18996295
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences